Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia

BACKGROUND: Selective low-density lipoprotein (LDL) apheresis is commonly used to treat patients with familial hypercholesterolemia (FH). Chemerin is an adipokine with putative roles in the regulation of lipid metabolism. METHODS: In our pilot study, we measured serum chemerin levels by enzyme-linke...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lipids Health Dis
Egile Nagusiak: Varga, Viktória E., Lőrincz, Hajnalka, Zsíros, Noémi, Fülöp, Péter, Seres, Ildikó, Paragh, György, Balla, József, Harangi, Mariann
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069981/
https://ncbi.nlm.nih.gov/pubmed/27756331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-016-0353-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak